A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with poor patient prognosis and limited therapeutic options. A lack of prognostic biomarkers and therapeutic targets fuels the need for new approaches to tackle this severe disease. Extracellular matrix degradation, release,...

Full description

Bibliographic Details

Published in:	Life
Main Authors:	Yueyang Liu, Weiwei Gong, Sarah Preis, Julia Dorn, Marion Kiechle, Ute Reuning, Viktor Magdolen, Tobias F. Dreyer
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Subjects:	triple-negative breast cancer KLK10 KLK11 mRNA
Online Access:	https://www.mdpi.com/2075-1729/12/10/1517